Price $170.14 |
Market Cap
76.71B
|
Sector Health Care |
Div. Growth
25.60%
|
|
P/E
38.8
|
P/B
17.73
|
P/S
9.84
|
Dividend %
0.90%
|
|
P/CF
-
|
P/FCF
97.0
|
Op. Cash Flow
2.15M
|
FCF
1.7
|
|
Op. Margin
32.40%
|
Net Margin
25.60%
|
ROE
45.70%
|
ROI
17.20%
|
|
ROA
14.80%
|
EPS Growth
1.40%
|
Current Ratio
2.4
|
Debt/Equity
148.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Wave Life Sciences Ltd (WVE) | $4.26 | - | - | 409.2M | Strong Buy |
| Leafbuyer Technologies Inc (LBUY) | $0.08 | - | - | 7.4M | Strong Buy |
| LAVA Therapeutics NV (LVTX) | $2.24 | - | - | 49.9M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $128.52 | - | - | 8.26B | Strong Buy |
| Item 9 Labs Corp (INLB) | $0.09 | - | - | 7.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
